Company Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally.
The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products.
It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand.
It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution.
The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019.
cbdMD, Inc. is based in Charlotte, North Carolina.
| Country | United States |
| Founded | 2015 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 42 |
| CEO | T. Kennedy |
Contact Details
Address: 2101 Westinghouse Blvd, Suite A Charlotte, North Carolina 28273 United States | |
| Phone | 704 445 3060 |
| Website | cbdmd.com |
Stock Details
| Ticker Symbol | YCBD |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001644903 |
| CUSIP Number | 12482W101 |
| ISIN Number | US12482W4087 |
| Employer ID | 47-3414576 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| T. Ronan Kennedy | Chief Executive Officer, Chief Financial Officer, Principal Executive Officer and Director |
| Bradley Whitford | Chief Accounting Officer, Treasurer and Secretary |
| Dr. Sibyl Swift Ph.D. | CSO, Vice President of Regulatory Affairs and Director |
| Zeb Booker | Chief Technology Officer |
| Lance Blundell | General Counsel |
| Francisco Mangual | Senior Vice President of Sales |
| Shannon Charles | Chief Marketing Officer |
| David Johnson | Senior Vice President of Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 4, 2026 | EFFECT | Notice of Effectiveness |
| Mar 4, 2026 | 424B4 | Prospectus |
| Feb 20, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Feb 17, 2026 | 10-Q | Quarterly Report |
| Feb 12, 2026 | DEF 14A | Other definitive proxy statements |
| Feb 2, 2026 | PRE 14A | Other preliminary proxy statements |
| Jan 22, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jan 20, 2026 | 10-K/A | [Amend] Annual report |
| Jan 14, 2026 | 424B3 | Prospectus |
| Jan 14, 2026 | 8-K | Current Report |